| Literature DB >> 29724214 |
Girma Gutema1, Helle Håkonsen2,3, Ephrem Engidawork4, Else-Lydia Toverud1.
Abstract
BACKGROUND: This project aims to study the use of antibiotics in three clinical wards in the largest tertiary teaching hospital in Ethiopia for a period of 1 year. The specific aims were to assess the prevalence of patients on antibiotics, quantify the antibiotic consumption and identify the main indications of use.Entities:
Keywords: Antibiotics; Ceftriaxone; Cephalosporin; Consumption; Ethiopia; Hospital; Tertiary
Mesh:
Substances:
Year: 2018 PMID: 29724214 PMCID: PMC5934805 DOI: 10.1186/s12913-018-3107-9
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Distribution of bed days (BD) for patients (n = 2231) admitted to three clinical wards at TASH during the one-year study period
| Clinical ward | Number of BD (%) | Mean number of BD (sd) | Number of patients with > 30 BD (%) |
|---|---|---|---|
| Internal medicine | 25,766 (70.1) | 20.1 (17.0) | 245 (19.1) |
| Gynecology/Obstetrics | 4974 (13.6) | 10.4 (9.9) | 54 (11.3) |
| Surgery | 5993 (16.3) | 12.7 (16.9) | 21 (4.4) |
| Total | 36,733 (100.0) | 16.5 (16.3) | 320 (14.3) |
Number of patients in the three clinical wards who were prescribed antibiotics for systemic use (ATC: J01) and number of sensitivity tests performed during the one year study period (n = 1645)
| Clinical ward | Number of patients prescribed antibiotics (%) | Number of sensitivity tests performed (%) |
|---|---|---|
| Internal Medicine | 939 (73.2) | 54 (5.8) |
| Gynecology/Obstetrics | 310 (64.9) | 5 (1.6) |
| Surgery | 396 (84.1) | 4 (1.0) |
| Total | 1645 (73.7) | 63 (3.8) |
Number of antibiotics prescribed to the patients in the three clinical wards during their hospitalization (n = 1645)
| Number of antibiotics per patient | 1 | 2 | 3 | 4 | 5–9 | Mean (sd) | |
|---|---|---|---|---|---|---|---|
| Number of patients (%) | Internal Medicine | 194 (20.7) | 383 (40.8) | 189 (20.1) | 94 (10.0) | 79 (8.4) | 2.5 (1.3) |
| Gynecology/Obstetrics | 213 (68.7) | 53 (17.1) | 26 (8.4) | 11 (3.5) | 7 (2.3) | 1.5 (1.0) | |
| Surgery | 236 (59.6) | 117 (29.5) | 27 (6.8) | 9 (2.3) | 7 (1.8) | 1.6 (0.9) |
Consumption in DDD/100BD and DDD/patient by class of antibiotics for systemic use (ATC: J01) in the three clinical wards at TASH during the one-year study period (n = 1645)
| Class of antibiotics | ATC Code | Antibiotic consumption | |||||
|---|---|---|---|---|---|---|---|
| Internal Medicine | Gynecology/Obstetrics | Surgery | |||||
| DDD/100BD | DDD/patient | DDD/100BD | DDD/Patient | DDD/100BD | DDD/patient | ||
| Third-generation cephalosporins | J01DD | 33.1 | 9.1 | 10.6 | 1.7 | 38.5 | 5.8 |
| Fluoroquinolones | J01MA | 11.4 | 3.1 | 1.8 | 0.3 | 1.9 | 0.3 |
| Imidazole derivatives | J01XD | 11.3 | 3.1 | 7.2 | 1.1 | 16.3 | 2.5 |
| Glycopeptides | J01XA | 8.9 | 2.4 | 1.1 | 0.2 | 5.2 | 0.8 |
| Sulfonamides and trimethoprim | J01EE | 7.8 | 2.1 | 0.9 | 0.1 | 0.2 | – |
| Macrolides | J01FA | 5.5 | 1.5 | 3.4 | 0.5 | 0.3 | 0.1 |
| Penicillins with extended spectrum | J01CA | 4.1 | 1.1 | 16.3 | 2.6 | 1.5 | 0.2 |
| Fourth-generation cephalosporins | J01DE | 3.1 | 0.9 | – | – | 1.3 | 0.2 |
| Penicillins plus beta-lactamase inhibitors | J01CR | 2.0 | 0.5 | 0.5 | 0.1 | 1.0 | 0.2 |
| Beta-lactamase-sensitive penicillins | J01 CE | 1.6 | 0.4 | 0.7 | 0.1 | – | |
| Other aminoglycosides | J01GB | 0.9 | 0.2 | 1.3 | 0.2 | 0.8 | 0.1 |
| Lincosamides | J01FF | 0.6 | 0.1 | – | – | 0.3 | 0.1 |
| Beta-lactamase-resistant penicillins | J01CF | 0.6 | 0.2 | 0.4 | 0.1 | 4.0 | 0.6 |
| Tetracyclines | J01AA | 0.3 | 0.1 | 2.3 | 0.4 | – | – |
| Carbapenems | J01DH | 0.2 | – | – | – | – | – |
| First-generation cephalosporins | J01DB | 0.2 | 0.1 | 1.1 | 0.2 | 0.2 | – |
| Streptomycins | J01GA | 0.1 | – | – | – | – | |
| Amphenicols | J01BA | 0.1 | – | – | – | 0.1 | – |
| Total | J01 | 91.8 | 24.8 | 47.6 | 7.6 | 71.6 | 10.9 |
Fig. 1The number of patients who were prescribed different antibiotics for systemic use (ATC: J01) during the one-year study period
Fig. 2Antibiotics constituting the drug utilization 90% (DU90%) in three clinical wards at TASH (n = 1645)